Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary metastasectomy for sarcoma-Essen experience.
Gafencu DA, Welter S, Cheufou DH, Ploenes T, Stamatis G, Stuschke M, Theegarten D, Taube C, Bauer S, Aigner C. Gafencu DA, et al. Among authors: stuschke m. J Thorac Dis. 2017 Oct;9(Suppl 12):S1278-S1281. doi: 10.21037/jtd.2017.07.47. J Thorac Dis. 2017. PMID: 29119015 Free PMC article.
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
Stuschke M, Eberhardt W, Pöttgen C, Stamatis G, Wilke H, Stüben G, Stöblen F, Wilhelm HH, Menker H, Teschler H, Müller RD, Budach V, Seeber S, Sack H. Stuschke M, et al. J Clin Oncol. 1999 Sep;17(9):2700-9. doi: 10.1200/JCO.1999.17.9.2700. J Clin Oncol. 1999. PMID: 10561344 Clinical Trial.
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.
Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M. Pöttgen C, et al. Among authors: stuschke m. Ann Oncol. 2002 Mar;13(3):403-11. doi: 10.1093/annonc/mdf050. Ann Oncol. 2002. PMID: 11996471 Free article. Clinical Trial.
Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy.
Pöttgen C, Levegrün S, Theegarten D, Marnitz S, Grehl S, Pink R, Eberhardt W, Stamatis G, Gauler T, Antoch G, Bockisch A, Stuschke M. Pöttgen C, et al. Among authors: stuschke m. Clin Cancer Res. 2006 Jan 1;12(1):97-106. doi: 10.1158/1078-0432.CCR-05-0510. Clin Cancer Res. 2006. PMID: 16397030 Free article.
Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer.
Eberhardt W, Gauler T, Pöttgen C, Krbek T, Korfee S, Stamatis G, Stuschke M. Eberhardt W, et al. Among authors: stuschke m. J Thorac Oncol. 2007 May;2(5 Suppl):S35-6. doi: 10.1097/01.JTO.0000268640.56073.d1. J Thorac Oncol. 2007. PMID: 17457229 Free article. No abstract available.
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M. Pöttgen C, et al. Among authors: stuschke m. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):809-15. doi: 10.1016/j.ijrobp.2009.02.022. Epub 2009 May 7. Int J Radiat Oncol Biol Phys. 2010. PMID: 19427744 Clinical Trial.
377 results